17 April 2019
Appointment of Claire Thomas as Independent Non-Executive Director
Persimmon Plc is pleased to announce that Claire Thomas will join the Board as an Independent Non-Executive Director with effect from 1 August 2019. Claire will also be appointed as a member of the Company's Remuneration and Nomination Committees on the same date.
Claire Thomas has been Senior Vice President, HR at GlaxoSmithKline PLC for more than 10 years with responsibility for the global HR function. Claire has over 28 years' experience of operating in a complex, global HR environment and has a wide range of experience including advising boards of directors, supporting remuneration and nomination committees, succession planning, strategic planning and corporate restructuring. Claire was also a Non-Executive Director for the UK Government's Department of Energy and Climate Change.
Roger Devlin, Chairman of Persimmon, said: "We are building a new Persimmon with progressive changes being made to our customer care, governance and remuneration. As part of that plan, we are further strengthening our board and remuneration committee with the appointment of a new, forward-thinking independent director with a strong track record in a highly respected global organisation. I am pleased to welcome Claire to Persimmon's board."
No further information is required to be disclosed pursuant to Listing Rule 9.6.13.
For further information, please contact:
Citigate Dewe Rogerson
Tel: +44 (0) 20 7638 9571
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Quick facts: Persimmon
Market Cap: £7.58 billion
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE